Picture of bluebird bio logo

BLUE — bluebird bio News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Bluebird Bio Inc - As Result of Restructuring Will Incur Aggregate Charges Of About $3.7 Million In Cash Expenditures

Sept 24 (Reuters) - bluebird bio Inc  BLUE.O :
    * BLUEBIRD BIO INC - AS RESULT OF RESTRUCTURING, ESTIMATES
THAT IT
WILL INCUR AGGREGATE CHARGES OF ABOUT $3.7 MILLION IN CASH
EXPENDITURES
    * BLUEBIRD BIO: RESTRUCTURING CHARGES TO BE PAID OUT OVER
MULTIPLE
WEEKS THROUGH FISCAL YEAR ENDING DEC 31 END

Source text for Eikon:  ID:n0001293971-24-000046 
Further company coverage:  BLUE.O 

 ((Reuters.Briefs@thomsonreuters.com))

Recent news on bluebird bio

See all news